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Abstract
Purpose In March 2015, the oral emergency contracep-
tives levonorgestrel (LNG) and ulipristal acetate (UPA)
were released from prescription-only status in Germany.
The main research question is to analyse whether the OTC
status of oral emergency contraceptives has an influence on
the patterns of use.
Methods All information is based on searches for public
domain sources on emergency contraception. Searches
were made for scientific publications, statistics, and
surveys.
Results Due to additional active ingredient properties,
UPA is superior to LNG in terms of ovulation-inhibiting
effect. Since the OTC switch, demand for oral emergency
contraceptives has risen by almost 50%, especially at
weekends when sexual encounters and thus contraceptive
failures are most frequent. However, the age distribution of
the users has not changed as a result of the OTC switch.
Doctors still play an important role in advising on emer-
gency contraception after the removal of the prescription-
only requirement. Pregnancies despite emergency contra-
ception are terminated in more than half of the cases. In
federal states with higher rates of use of the morning-after
pill, fewer terminations of pregnancy were performed.
Conclusion As a result of the OTC switch, more women
and girls use the morning-after pill after unprotected
intercourse and the time between unprotected intercourse
and taking the oral emergency contraceptive decreases.
This is of great advantage in terms of the mechanism of
action. UPA is used more frequently than LNG. Only half
of all people aged between 16 and 39 years in Germany are
aware of the morning-after pill and 94% of women who
had a pregnancy terminated in 2015 did not use any
emergency contraception after the unprotected intercourse.
In the population, there is sti
ll a great need for information and education on contra-
ception and emergency contraception.
Keywords Morning-after pill  Ulipristal acetate (UPA) 
Levonorgestrel (LNG)  Unprotected intercourse 
Unintended pregnancy
Introduction
As of 15 March 2015, levonorgestrel (LNG) and ulipristal
acetate (UPA) are also available in Germany as prescrip-
tion-free emergency contraceptives. The basis for this
decision was the existing evidence on the two active
ingredients: if taken soon enough, UPA (ellaOne) and
LNG (PiDaNa) effectively delay ovulation, and both have
a relatively good drug safety profile [1]. The probability of
preventing an unintended pregnancy with oral emergency
contraceptives is greatest if they are taken quickly. The
low-threshold access in terms of the mechanism of action
was thus a further important argument for releasing oral
emergency contraceptives from prescription-only status.
This decision was a topic of controversy amongst the
various partners in the healthcare system.
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The purpose of this study is, therefore, to analyse the
following questions after 1 year of OTC status:
• Which active ingredients with which mechanisms of
action are available?
• What influence has the OTC status of oral emergency
contraceptives had on patterns of use?
• Has the user profile changed as a result of the OTC
status?
• What role do doctors play since removal of the
prescription requirement?
• How high are the pregnancy rates of emergency
contraceptive pills and what effects does it have on
the pregnancy if the contraceptive action fails?
• Are there effects on the number of pregnancy termi-
nations as a result of the release of oral emergency
contraceptives from prescription-only status?
• How well is the population informed about the
morning-after pill?
Methods
The NLM PUBMED literature database was searched for
data on oral emergency contraceptives, available active
ingredients, and their mechanisms of action. The search
terms used were ‘‘emergency contraception’’ and ‘‘emer-
gency contraception mode of action’’. The first available
publication matching the respective search term and all the
following publications up to the date of the current search
(24.06.2016) were taken into account. A search was made
for publicly available online statistics to obtain up-to-date
figures on the population, on pregnancies, and on termi-
nations of pregnancy.
To evaluate the market trend, the sales figures for oral
emergency contraceptives by active ingredient of IMS
HEALTH GmbH & Co. OHG were used [11]. The analysis
of the user rate in European comparison is based on the
sales figures for European countries of IMS HEALTH
GmbH & Co. OHG and on the worldwide population
statistics of 15–49-year-old women published in 2012 by
the Department of Economic and Social Affairs of the
United Nations [13].
The figures on use of oral emergency contraception after
unprotected intercourse are based on the figures of IMS
HEALTH GmbH & Co. OHG for oral emergency contra-
ceptives sold in 2015 [11], compared with the percentage
of women between 14 and 49 years in Germany according
to the latest population figures published by the German
Federal Office of Statistics in 2014 [14] who are sexually
active according to a study on the sexual behaviour of
Germans conducted in 2011 by the company Durex [15]
and who had experienced a contraceptive failure in the last
12 months according to a European survey by the company
BVA Healthcare [22].
The figures on the frequency of use of oral contracep-
tives in a woman’s life were based on the figures of a
representative survey by the German Federal Centre for
Health Education on the contraceptive behaviour of adults
[16].
An EMNID survey conducted in December 2015 with
1000 interviewees aged between 16 and 39 years was used
as the basis for the frequency of sexual intercourse in the
course of the week [17]. The percentages of oral emer-
gency contraceptives sold per day of the week at the time
of prescription-only status were determined on the basis of
a Medimed Prescriber study on the prescribing frequency
of the morning-after pill in doctors’ practices on the basis
of 14,223 prescriptions in 2010 [18]. The day-of-the-week
data after removal of the prescription-only requirement
were obtained from the day-of-the-week study on the
morning-after pill from October to December 2015 by IMS
HEALTH GmbH & Co. OHG [19].
For examination of the effects on the user profiles, the
age data at the time of prescription-only status were com-
pared with the data after the switch to OTC status. For this
purpose, the figures for the first half of 2010 from the study
by medimed GmbH on the age distribution of the morning-
after pill users [20] were compared with the figures for
July/August 2015 from the market research conducted by
HRA Pharma Deutschland GmbH covering 1018 pharma-
cies [21].
The reasons for using hormonal emergency contra-
ception were obtained from a Europe-wide study con-
ducted by the company BVA Healthcare in 2012 [22]. For
this study, 10,983 women were interviewed. The results
showed that 2129 of the women interviewed had unpro-
tected intercourse in the last 12 months. The data on use
of emergency contraception by these study participants
were used.
The figures on unintended pregnancies are based on data
from a study on family planning in the lives of women with
a focus on unintended pregnancies commissioned by the
German Federal Centre for Health Education and published
in 2016 [23].
The role of doctors after the switch to OTC status was
evaluated on the basis of two sources: on one hand, the
analysis of prescriptions for oral emergency contraceptives
by IMS HEALTH GmbH & Co. OHG from the year 2015
[24] and on the other hand, a representative online study by
the market research institute YouGov with the title ‘‘Let’s
talk von Frau zu Frau’’ [Let us talk from woman to woman]
in which 1038 women were interviewed in March 2016
[26].
The data on the pregnancy rates on UPA and LNG are
based on the meta-analysis published in The Lancet in 2010
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[27] in which the results of the two available comparative
studies on UPA and LNG were taken into account [27, 29].
The data on pregnancies since market authorisation were
taken from the pharmacovigilance data on ellaOne pub-
lished in 2014 in the journal Contraception [32] and from
the annual report on reports of adverse drug reactions on
ellaOne from May 2014 to May 2015 (periodic safety
update report ellaOne No. 9) [31].
The number of terminated pregnancies as a percentage
of all pregnancies was calculated from the figures on the
number of terminations of pregnancy [35] and the number
of births in Germany [34], both of which are given on the
statistics site Statista.
The pregnancy terminations per 10,000women by federal
state given on Statista for the year 2015 [35] were compared
with the rates of use of emergency oral contraceptives by
15–49-year-old women by federal state. To determine the
rates of use of oral emergency contraceptives by 15–49-year-
old women by federal state, the figures of IMS HEALTH
GmbH&Co. OHG on sale of oral emergency contraceptives
[11] were compared with the numbers of 15–49-year-old
women in the respective federal states [14].
The figures on the use of oral emergency contraceptives
by women who had a pregnancy terminated in 2015 were
calculated from figures of IMS HEALTH GmbH & Co.
OHG on the number of emergency contraceptives sold in
2015 [11], compared with the number of unintended
pregnancies in spite of taking oral emergency contracep-
tives according to the data from the meta-analysis [27] and
the number of terminations of pregnancy in the whole of
Germany in 2015 given on Statista [35].
The awareness of the morning-after pill in the popula-
tion was determined by an EMNID survey commissioned
by HRA Pharma GmbH in the summer of 2015 for which
1000 men and women were interviewed [37].
Results
Available data on active ingredients
and mechanisms of action
The available data on the mechanism of action of the two
active ingredients are extensive. For the search term
‘‘emergency contraception’’ alone, there are 3318 publi-
cations in PUBMED (1947–24.06.2016) and 1354 of which
are on the topic of mechanism of action of emergency
contraceptives (1953–24.06.2016). From 2002 onwards,
there is a sharp increase in publications on the subject
mechanism of action. According to the most recent studies,
the mechanism of action of oral emergency contraceptives
is as follows: if taken early enough, UPA (ellaOne) and
LNG (e.g., PiDaNa) delay ovulation [1]. Through
agonistic effects on the progesterone receptors of the
hypothalamus–pituitary–gonadal axis, UPA and LNG
exercise negative feedback and thus suppress the release of
FSH and particularly LH by the pituitary [2, 3]. Through
the suppression and delay of the LH peak, an important
trigger of ovulation is missing, thus resulting in inhibition
of ovulation.
UPA, as selective progesterone receptor modulator
(SPRM), also has additional effects. Pharmacodynamic
studies were able to show that UPA also has ovulation-
inhibiting action during the LH increase [4]. When the LH
increase occurs in the progesterone receptor, agonist LNG
loses its effect. The LH increase (approximately 2 days
before ovulation) marks the beginning of the most fertile
phase of the cycle. The likelihood of conception on these 2
days is about 30% [5]; however, on account of the vari-
ability of ovulation, the time of this phase cannot be pre-
dicted [6].
A further additional effect of the SPRM UPA is on the
pre-ovulatory progesterone surge. An increased concen-
tration of follicular progesterone together with increased
oestrogen and LH levels is a further essential trigger of
ovulation [7, 8]. According to pharmacodynamic studies,
UPA has an inhibitory effect on the pre-ovulatory pro-
gesterone surge [4].
On the follicular level, selectively antagonistic effects of
the SPRM UPA are also relevant. Studies in animals
showed evidence of the direct antagonistic effects on the
follicular level [9]. It was shown on receptor level that
activation of the follicular progesterone receptors is nec-
essary for activation of the signal cascade which ultimately
leads to ovulation. UPA blocks this signal cascade and can
have an additional ovulation-inhibiting action via this
direct follicular effect. On the other hand, LNG, as pure
progesterone receptor agonist, does not block the follicular,
progesterone receptor-mediated signal cascades which lead
to triggering of ovulation.
On account of these three additional effects, the SPRM
UPA is superior to the progesterone receptor agonist LNG
with regard to inhibition of ovulation [4]. UPA is also
effective in the most fertile phase of the cycle, during the
LH increase, up to shortly before ovulation. The effective
window of LNG on the other hand ends 2–3 days before
ovulation with the start of the LH increase. The develop-
ment of UPA as emergency contraceptive thus represents a
considerable advance in contraception, particularly on
account of its diverse mechanisms of action and low side-
effect rate [10].
Pattern of use
The analysis of the sale figures for oral emergency con-
traceptives shows, since the switch to OTC status
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approximately 60,000 packs of hormonal emergency con-
traceptives per month is dispensed by pharmacies. In
comparison with the era of prescription-only status, the
market has increased by almost 50% [11]. A look at the
development of the market of oral emergency contracep-
tives from 2014 to 2015 by active ingredient shows a
growth in the market from March 2015 onwards [11]. With
the removal of the prescription-only requirement in March
2015, there was a sharp increase in the number of morning-
after pills sold from about 40,000 per month to approxi-
mately 52,000.
Looking at the market growth by active ingredient, we
see that the trend set in motion by the gynaecological
experts has continued: since 2013 UPA has been the
standard for emergency contraception for German gynae-
cologists [12]. After the switch to OTC status, the superior
efficacy of UPA over LNG is still utilised. About two-
thirds of the morning-after pills sold and contain the SPRM
UPA [11].
Looking at the user rate, we see that in 2015, 3.9% of the
women between 15 and 49 years of age in Germany used
the morning-after pill [13].
The European comparison (Fig. 1) shows that in spite of
the market growth, oral emergency contraceptives are still
used relatively seldom in Germany. The top users in Eur-
ope are Sweden, Norway, and France with more than 11%
of all 15–49-year-old women. The rate of 3.9% in Germany
is well below the EU average of 6.7%.
Estimates show that only 30% of women in Germany use
emergency contraceptives after unprotected intercourse to
prevent an unintended pregnancy [11, 14, 15, 22] and they
usually only use emergency contraceptives once in a lifetime.
In a representative survey by the German Federal Centre for
Health Education, only 2% of all users reported that they had
taken the morning-after pill more than once [16].
According to a recent survey, men and women report
that 86% of sexual encounters take place at weekends [17].
The likelihood of contraceptive failures at weekends is
correspondingly great. Through the OTC status, women do
in fact make use of the rapid access to oral emergency
contraception [18, 19]. Thus, the percentage of oral
emergency contraceptives sold at the weekend has
increased from 7% when the prescription-only requirement
was in place to currently 28% (Fig. 2). This means that
after unprotected intercourse, more women now make use
of the easier access to emergency contraception at
weekends.
User profile
A feared fall in the age of emergency contraceptive users
has not occurred: the age of the users of oral emergency
contraceptives has not changed as a result of the switch to
OTC status [20, 21]. More than two-thirds of users are still
over 20 years of age (Fig. 3).
In more than half of the cases, the reasons for taking
hormonal emergency contraceptives are failure or forget-
ting of contraceptive precautions. In a European-wide
survey by BVA Healthcare, 39% of the German women
interviewed reported condom failure, 34% missed pills,
21% no contraception, 9% a contraceptive pause, and 9%
other reasons [22]. Thus, the most common reason for
using oral emergency contraceptives is not ‘‘no contra-
ception’’ but failure or forgetting of contraceptives.
Hence, unprotected intercourse occurs mainly as a result
of contraceptive failure. This also confirms a survey by the
German Federal Centre for Health Education on unin-
tended pregnancies. In this survey, 35.8% of the women
who had become pregnant unintentionally stated that they
had in fact regularly used contraceptives [23] with 52%
using oral contraceptives and 31% using condoms.
The role of doctors
Doctors—particularly gynaecologists—continue to play an
important role for users of oral emergency contraceptives
in spite of the fact that the prescription requirement has
been lifted. Pharmacies have the option of referring a
customer to a doctor at any time, particularly if unclear
issues arise during their counselling, e.g., in the case of
medical conditions, such as an increased risk of throm-
boembolic events, severe liver impairment, or epilepsy.
In 2015, 17% of oral emergency contraceptives were
dispensed on prescription [24]. Thus, even after the switch
to OTC status, some women and girls go directly to a
gynaecologist. This is partly because of ignorance about
the OTC status of the morning-after pill but also to obtain a
prescription for the purpose of reimbursement. In the pro-
cess of the switch to OTC status for oral emergency con-
traceptives, the ‘‘Fourteenth Ordinance on Amendment of
Prescribing of Medicinal Products’’ [Vierzehnte Verord-
nung zur A¨nderung der Arzneimittelverschrei-
bungsverordnung] initiated a corresponding amendment of
Article 24a of Book Five of the German Social Security
Code (SGB V). This means that doctors can also prescribe
non-prescription emergency contraceptives on a statutory
health insurance prescription. For women under the age of
20, emergency contraceptives are reimbursable. For
women aged 18–20, there is a prescription fee of €5. In
spite of regulation of the reimbursability, 17% of oral
emergency contraceptives prescribed 12% were prescribed
on a private prescription [24].
Further reasons why some women go directly to a
gynaecologist after unprotected intercourse may be to have
an unplanned pregnancy ruled out with certainty or to use a
contraceptive method regularly in the future [25].
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The main source of information about the morning-after
pill is still the doctor even after the switch to OTC status.
This is the result of a recent survey [26]. Almost every
second, woman in Germany (44%) who sought information
about the morning-after pill consulted a doctor for this
purpose. Further popular sources of information are search



























































Fig. 1 Use of oral emergency
contraceptives in Europe as a
percentage of the female
population of the respective





























Fig. 2 Sales of hormonal emergency contraceptives by day of the week at the time of prescription-only status and after switch to OTC status
[18, 19]
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Pregnancy rates after emergency contraception
According to the currently available data, the mechanism
of action of oral emergency contraceptives is inhibition of
ovulation with delay of ovulation [4]. On account of
additional active ingredient properties (inter alia stabilisa-
tion of the follicle) of the SPRM UPA, the ovulation-in-
hibiting action of UPA is superior to that of LNG [4]. The
high variability of ovulation must be taken into account [6].
Analysis of the two available comparative studies shows
that the pregnancy rate on UPA is lower compared with the
morning-after pill containing LNG [27]: 0.9% (UPA) vs
2.3% (LNG) when taken within 24 h after the unprotected
intercourse, 1.4% (UPA) vs 2.2% (LNG) if taken within
72 h, and 1.3% (UPA) vs 2.2% (LNG) if taken within
120 h. For this reason, the morning-after pill containing
UPA (ellaOne) has been the standard for German
gynaecologists since 2013 [12].
Analyses (Lancet meta-analysis [27] and Cochrane
Review [28]) of the only available two comparative studies
[27, 29] show that UPA is superior to LNG.
The superior effectiveness is most marked when UPA is
taken within 24 h after the unprotected intercourse (Fig. 4).
In its fact sheet, the WHO for the first time recognizes
the superiority of UPA over LNG: the fact sheet states that
if LNG is used within 72 h pregnancy can be prevented in
52–94% of the cases. Studies show that, if used within 72 h
after unprotected intercourse, UPA can prevent unintended
pregnancies in at least 98% of cases [30].
If LNG or UPA is not used soon enough before, ovu-
lation pregnancy is possible in spite of emergency contra-
ception. From the launching of 30 mg UPA for emergency
contraception (ellaOne) in October 2009 to May 2015,
604 pregnancies were reported to the manufacturer [31].
The outcome of 207 (34.3%) of the reported pregnancies is
not known. At the time of publication of the pregnancy
data, 59 (14.9%) of the ellaOne pregnancies with known
outcome were still ongoing and 60 (15.1%) pregnancies
resulted in live births. These data show no indications of an
increased risk of malformations or complications [31, 32].
Pregnancy in spite of oral emergency contraception is thus
not an indication for termination.
Terminations of pregnancy after emergency
contraception
According to the pharmacovigilance databases, 65% of
pregnancies occurring after use of UPA were terminated
[32].
Just under, 34% of all pregnancies in Germany are
unplanned or unintended [23]. More than half of all unin-
tended pregnancies are electively terminated [33]. In Ger-
many, one in eight of all pregnancies is electively
terminated [34, 35].
The absolute number of terminations of pregnancy in
2015 did not change significantly compared with 2014: in
2014, 99,715 terminations of pregnancy were performed
and in 2015 99,237 [35]. However, when looking at the
absolute figures on termination of pregnancy, changes in
the population structure must also be taken into account. In
2015, many migrants entered Germany. Nothing can be
said about the development of pregnancy terminations in
relation to the population until the population figures for
the year 2015 become available [36].
If we compare the figures for pregnancy terminations
per 10,000 women in 2015 by federal state [35] with the
rates of use of emergency contraceptive pills by 15–49-
year-old women [11, 14], the following trend can be
identified: in federal states with a low rate of use of
emergency contraception, the pregnancy terminations per
10,000 women are higher. In Saxony-Anhalt, 86 of 10,000
women terminated a pregnancy in 2015. The percentage of
15–49-year-old women in Saxony-Anhalt who used the
morning-after pill in 2015 was 1.95%. In Bavaria, on the
other hand, the pregnancy termination rate is more than
two times lower: in 2015, only 41 out of 10,000 women
were electively terminated a pregnancy. Compared with









Up to 14 years 14–20 years 21–35 years over 35 years
Fig. 3 Age distribution of users
of oral emergency
contraceptives at the time of
prescription-only status and
after the switch to OTC status
[20, 21]
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contraceptives by 15–49-year-old women was 4.69% and
thus more than twice as high (Fig. 5). These figures un-
derline the importance of information and education about
contraception and emergency contraception to avoid
unintended pregnancies.
Level of knowledge amongst the population
On the basis of the figures for 2015 on sale of emergency
contraceptives [11], the failure rate [27], and terminations
of pregnancy [35], it can be estimated that about 94% of
the women who electively terminated a pregnancy had not
taken any action to prevent a pregnancy after the unpro-
tected intercourse. These figures show that more informa-
tion and education on contraception and emergency
contraception are needed. The lack of knowledge of the
option emergency contraception in the population is con-
firmed by a recent survey of 1000 women and men aged
between 16 and 39 [37]: only 53% mentioned the morning-
after pill as a possible way of preventing an unintended
pregnancy after unprotected intercourse. In the higher
income brackets (monthly income €3000–3500), as many
as 32% gave termination of pregnancy as an alternative.
Discussion
The analysis of the available data on emergency contra-
ception shows that as a result of the easier access to oral
emergency contraception, more women and girls use the
morning-after pill after unprotected intercourse. As a result
of the switch to OTC status, the time between unprotected
intercourse and the dispensing of emergency contraceptive
pills by a pharmacy is shortened. This is of great advantage
with regard to the mechanism of action of oral emergency
contraceptives. The early use of oral emergency contra-
ceptives increases the likelihood of pre-empting ovulation,
and the occurrence of an unintended pregnancy can thus be
prevented.
On account of the available evidence showing the
superior effectiveness and lower pregnancy risk of UPA
compared with LNG, preference is still given to UPA, and
the standard medication used by gynaecologists for emer-
gency contraception. The market growth in oral emergency
contraceptives is accounted for mainly by UPA.
In spite of the market growth, oral emergency contra-
ceptives are used relatively seldom after unprotected
intercourse in Germany. This is shown by comparative data
for other European countries, estimates of the frequency of
unprotected intercourse, and the figures on unintended
pregnancies.
The age profile of the users of emergency contraceptives
has not changed as a result of the switch to OTC status. In
addition, there is no evidence of an effect on the absolute
number of terminations of pregnancy since introduction of
OTC status.
It has not been possible to show to date that low-
threshold access to emergency contraception alone is able
to reduce the number of terminations of pregnancy [38]. It
must be taken into account here that there are many reasons
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Fig. 4 Comparison of effectiveness of UPA and LNG. UPA is superior to LNG, particularly if taken quickly [27, 28]
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for termination of pregnancy. There is no monocausal
connection between emergency contraceptives and elective
termination of pregnancy. Further important factors which
influence the frequency of termination of pregnancy are
knowledge and level of education, contraceptive beha-
viour, accessibility, and costs of contraceptives.
There is, however, happily evidence of a positive trend
in Germany: in federal states with a high rate of use of
emergency oral contraceptives, the termination rate is
lower compared with states in which emergency contra-
ceptives are used less often.
Only half of all young adults in Germany are aware of
the possibility of emergency contraception with the help of
the morning-after pill. This shows that emergency contra-
ception is still a taboo topic and that intensive educational
efforts are still needed. The necessary educational work is
additionally impeded by the advertising ban decided on by
the German parliament in 2015.
Doctors, who are the most important source of
information for the morning-after pill for the general
public, also have an information deficit regarding the
prescribing of drugs with OTC status. More than 70%
of the morning-after pills prescribed were prescribed
on a private prescription despite the fact that for under
20 years, the morning-after pill is reimbursable and
can be prescribed on a statutory health insurance
prescription.
In addition to information and education about emer-
gency contraception, easy and rapid access to oral emer-
gency contraception is of great importance. If a woman
wants to prevent an unintended pregnancy using the
morning-after pill after unprotected intercourse, early use
of oral emergency contraception increases the likelihood
of success. If UPA is taken within 24 h after the unpro-
tected intercourse, the pregnancy risk can be reduced to
0.9% [27].
Core statements
• LNG and UPA are approved in Germany for emergency
contraception and have been available without pre-
scription from pharmacies since March 2015.
• UPA prevents unintended pregnancies more effectively
than LNG, particularly when used within 24 h after the
unprotected intercourse.
• The demand for oral emergency contraceptives has
increased by almost 50% as a result of the switch to
OCT status.
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Fig. 5 Terminations of pregnancy per 10,000 women in 2015 [35]
and the percentage rates of use of oral emergency contraceptives by
federal state [11, 14]. Federal states with a higher rate of use of oral
emergency contraceptives have lower rates of termination of preg-
nancy. The rates of use of oral emergency contraceptives in 2015 are
calculated on the basis of the data on oral emergency contraceptives
from IMS Health and HRA Pharma Deutschland GmbH [11]. The
market figures are shown as a percentage of the 15–49-year-old
women per federal state on the basis of the population of 2014 [14]
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• Doctors still play an important role in advising on
emergency contraception even after the switch to OTC
status.
• In federal states with high rates of use of the morning-
after pill, there was a trend towards fewer terminations
of pregnancy in 2015.
• There is still a great need for information and education
on emergency contraception in the population.
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